These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 30944201)

  • 1. LOXL1-AS1 predicts poor prognosis and promotes cell proliferation, migration, and invasion in osteosarcoma.
    Chen S; Li W; Guo A
    Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30944201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA CBR3-AS1 predicts unfavorable prognosis and promotes tumorigenesis in osteosarcoma.
    Zhang Y; Meng W; Cui H
    Biomed Pharmacother; 2018 Jun; 102():169-174. PubMed ID: 29554595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of long non-coding RNA DBH-AS1 inhibits osteosarcoma progression by PI3K-AKT signaling pathways and indicates good prognosis.
    Liu ZB; Wang JA; Lv RQ
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1418-1427. PubMed ID: 30840262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA LOXL1-AS1 Promotes the Proliferation and Metastasis of Medulloblastoma by Activating the PI3K/AKT Pathway.
    Gao R; Zhang R; Zhang C; Liang Y; Tang W
    Anal Cell Pathol (Amst); 2018; 2018():9275685. PubMed ID: 30050750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role and clinical significance of long noncoding RNA zinc finger E-box-binding homeobox two antisense RNA 1 in promoting osteosarcoma cancer cell proliferation, inhibiting apoptosis and increasing migration by regulating miR-145.
    Zhou Y; Feng D; Gu X; Gao A; Liu Y
    Anticancer Drugs; 2021 Feb; 32(2):168-177. PubMed ID: 32826416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of Long Non-Coding RNA NNT-AS1 Correlates with Tumor Progression and Poor Prognosis in Osteosarcoma.
    Ye H; Lin J; Yao X; Li Y; Lin X; Lu H
    Cell Physiol Biochem; 2018; 45(5):1904-1914. PubMed ID: 29518771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The lncRNA HNF1A-AS1 is a negative prognostic factor and promotes tumorigenesis in osteosarcoma.
    Cai L; Lv J; Zhang Y; Li J; Wang Y; Yang H
    J Cell Mol Med; 2017 Nov; 21(11):2654-2662. PubMed ID: 28866868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA FAL1 is a negative prognostic biomarker and exhibits pro-oncogenic function in osteosarcoma.
    Wang Y; Zhao Z; Zhang S; Li Z; Li D; Yang S; Zhang H; Zeng X; Liu J
    J Cell Biochem; 2018 Nov; 119(10):8481-8489. PubMed ID: 29987852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA SOX2-OT is a novel prognostic biomarker for osteosarcoma patients and regulates osteosarcoma cells proliferation and motility through modulating SOX2.
    Wang Z; Tan M; Chen G; Li Z; Lu X
    IUBMB Life; 2017 Nov; 69(11):867-876. PubMed ID: 28960757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulated Long Non-Coding RNA MSC-AS1 Inhibits Osteosarcoma Progression and Increases Sensitivity to Cisplatin by Binding to MicroRNA-142.
    Zhang L; Zhao G; Ji S; Yuan Q; Zhou H
    Med Sci Monit; 2020 Mar; 26():e921594. PubMed ID: 32155139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA MATN1-AS1 for Prediction of Prognosis in Osteosarcoma Patients and Its Cellular Function.
    Liu Y; Wang D; Ji Q; Yan J
    Mol Biotechnol; 2022 Jan; 64(1):66-74. PubMed ID: 34542816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA HOXD-AS1 aggravates osteosarcoma carcinogenesis through epigenetically inhibiting p57 via EZH2.
    Gu W; Zhang E; Song L; Tu L; Wang Z; Tian F; Aikenmu K; Chu G; Zhao J
    Biomed Pharmacother; 2018 Oct; 106():890-895. PubMed ID: 30119259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA ABHD11-AS1 predicts the prognosis of pancreatic cancer patients and serves as a promoter by activating the PI3K-AKT pathway.
    Qiao X; Lv SX; Qiao Y; Li QP; Ye B; Wang CC; Miao L
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8630-8639. PubMed ID: 30575903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA SNHG20 is associated with clinical progression and enhances cell migration and invasion in osteosarcoma.
    Zhang J; Ju C; Zhang W; Xie L
    IUBMB Life; 2018 Nov; 70(11):1115-1121. PubMed ID: 30120876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA DSCAM-AS1 promoted cell proliferation and invasion in osteosarcoma by sponging miR-101.
    Yu CL; Xu NW; Jiang W; Zhang H; Ma Y
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7709-7717. PubMed ID: 32744697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of long non-coding RNA NNT-AS1 promotes osteosarcoma progression by inhibiting the tumor suppressive miR-320a.
    Li C; Zhang S; Qiu T; Wang Y; Ricketts DM; Qi C
    Cancer Biol Ther; 2019; 20(4):413-422. PubMed ID: 30489194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SP1-mediated upregulation of lncRNA LMCD1-AS1 functions a ceRNA for miR-106b-5p to facilitate osteosarcoma progression.
    He JW; Li DJ; Zhou JH; Zhu YL; Yu BQ
    Biochem Biophys Res Commun; 2020 Jun; 526(3):670-677. PubMed ID: 32248969
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Luo Y; Tao H; Jin L; Xiang W; Guo W
    Cancer Biother Radiopharm; 2020 Feb; 35(1):58-65. PubMed ID: 31724892
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum lncRNA LOXL1-AS1 is a diagnostic and prognostic marker for epithelial ovarian cancer.
    Liu CN; Zhang HY
    J Gene Med; 2020 Oct; 22(10):e3233. PubMed ID: 32449981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA BLACAT1 accelerates the proliferation and migration of osteosarcoma cells through regulating STAT3.
    Dong Z; Wang Y
    Pathol Res Pract; 2019 Mar; 215(3):571-579. PubMed ID: 30665678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.